US President-elect Trump: The Abraham Agreement will be expanded and Saudi Arabia will be added.Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.
Yuanda Environmental Protection: It is planned to invest in the flue gas treatment franchise project of 2× 1,000 MW units in Huainan Pingwei Power Plant Phase IV, reaching the environmental protection announcement. The franchise company, a wholly-owned subsidiary, plans to set up Pingwei Branch, build desulfurization, denitrification and dust removal facilities based on the 2× 1,000 MW units in Pingwei Power Plant Phase IV, and sign a franchise contract with Pingwei Power Plant to carry out the flue gas treatment franchise business. The static investment of the project is 641 million yuan, the dynamic investment is 662 million yuan, and the franchise period is not less than 20 years. It is estimated that the total annual profit of the project is 18.89 million yuan and the average annual net profit is 13.45 million yuan. This transaction will help Yuanda Environmental Protection to further expand its market in Anhui and surrounding areas, obtain long-term stable income and form new profit growth points.Commander-in-Chief of Russian Navy: The naval sub-group of Russian nuclear forces has been completely updated.Gao Weibing: Guangzhou Institute will improve the variety layout of new energy and new materials. On December 12th, 2024 China New Energy and New Materials Industry Conference was held in Guangzhou. Gao Weibing, Party Secretary and Chairman of Guangzhou Futures Exchange, said that in the near future, Guangzhou Futures Exchange will launch polysilicon futures and options to form a linkage with industrial silicon, providing more effective price signals and risk management tools for the photovoltaic industry chain. In the next step, Guangzhou Institute will thoroughly implement the spirit of "Opinions on Strengthening Supervision and Preventing Risks to Promote the High-quality Development of Futures Market", based on the fundamental purpose of serving the real economy and the characteristic orientation of serving the green development, improve the variety layout of new energy and new materials, increase market cultivation, continuously enrich the supervision toolbox, and strive to ensure the safe and stable operation of the market and better serve the needs of the real economy. (China Nonferrous Metals News)
Wanchen Group: It is planned to purchase 16 "New Zero Help" software systems of Nanjing Zhongcheng for 27.7031 million yuan. Wanchen Group announced that in order to meet the needs of the company and its holding subsidiaries to carry out daily business activities, the company plans to purchase 16 "New Zero Help" software systems held by Nanjing Zhongcheng at a transaction price of 27.7031 million yuan (including tax). Nanjing Zhongcheng is a related party of the company, and this transaction constitutes a related party transaction. According to the announcement, the software system is specially designed for retail and wholesale enterprises, mainly for medium and large retail enterprises.The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14